Production will begin in December and the vaccine will be exported to countries around the world starting in January 2021.
The first interim results of a large-scale Phase III clinical trial for the jab were released earlier this week and showed 92-percent efficacy. Researchers said they would publish their preliminary findings in a top medical journal and promised to make available a full clinical trial report once the testing phase is complete. They said it would take up to six months to ensure that participants in the trials do not suffer any side effects.
Developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V is the world’s first registered Covid-19 vaccine. It is now undergoing the Phase III clinical trial involving 40,000 volunteers.
Other countries are also taking part in testing the vaccine. Belarus, the UAE, Venezuela, and India are conducting their own clinical trials of Sputnik V, and could potentially purchase doses, or licensing rights to produce the vaccine, for domestic distribution.
Like this story? Share it with a friend!
© 2020, paradox. All rights reserved.
Israel is willing to pause its military offensive in Gaza if Hamas releases all the…
The EU’s top diplomat, Josep Borrell, has admitted that not every member state agrees to…
Russia’s Defense Ministry has published a video clip from the front line with Ukraine showing…
Donald Trump is eyeing plans to push the NATO members to ramp up defense spending…
Former US President Donald Trump paid the $9,000 fine for violating a gag order imposed…
Russian forces are steadily advancing in the Ukraine conflict, the US Director of National Intelligence,…